Literature DB >> 11531619

Evaluation of HPV testing by Hybrid Capture II for routine gynecologic screening.

P Schneede1, P Hillemanns, F Ziller, A Hofstetter, E Stockfleth, R Arndt, T Meyer.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11531619     DOI： 10.1034/j.1600-0412.2001.080008750.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN： 0001-6349            Impact factor:   3.636


× No keyword cloud information.
  7 in total

1.  Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study.

Authors:  Anna Gillio-Tos; Laura De Marco; Francesca Maria Carozzi; Annarosa Del Mistro; Salvatore Girlando; Elena Burroni; Helena Frayle-Salamanca; Paolo Giorgi Rossi; Paola Pierotti; Guglielmo Ronco
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

2.  Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.

Authors:  Anna Söderlund-Strand; Per Rymark; Pia Andersson; Joakim Dillner; Lena Dillner
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  [Condylomata acuminata: an indication for prophylactic HPV vaccination?].

Authors:  P Schneede; B Schlenker; E Hungerhuber
Journal:  Urologe A       Date:  2006-12       Impact factor: 0.639

4.  Human papillomavirus genotype specificity of hybrid capture 2 low-risk probe cocktail.

Authors:  Mario Poljak; Bostjan J Kocjan; Anja Kovanda; Maja M Lunar; Snjezana Zidovec Lepej; Ana Planinic; Katja Seme; Adriana Vince
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

5.  Human papillomavirus genotype specificity of hybrid capture 2.

Authors:  Philip E Castle; Diane Solomon; Cosette M Wheeler; Patti E Gravitt; Sholom Wacholder; Mark Schiffman
Journal:  J Clin Microbiol       Date:  2008-06-25       Impact factor: 5.948

6.  Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools.

Authors:  S-M Kulmala; S Syrjänen; I Shabalova; N Petrovichev; V Kozachenko; J Podistov; O Ivanchenko; S Zakharenko; R Nerovjna; L Kljukina; M Branovskaja; V Grunberga; A Juschenko; P Tosi; R Santopietro; K Syrjänen
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

7.  Comparative study between the Hybrid Capture II test and PCR based assay for the detection of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma.

Authors:  Ajay Kumar Chaudhary; Shruti Pandya; Ravi Mehrotra; Alok C Bharti; Mangal Singh; Mamta Singh
Journal:  Virol J       Date:  2010-09-23       Impact factor: 4.099
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.